Sandbox:Polio prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 27: Line 27:
| style="padding: 5px 5px; background: #F5F5F5;" align="center"| ✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center"| ✔
|-
|-
| colspan="7" † <SMALL><SMALL>Countries at high risk for importation and subsequent spread</SMALL></SMALL><br> ‡ <SMALL><SMALL>Countries at high risk for importation and subsequent spread</SMALL></SMALL>
| colspan="7" | † <SMALL><SMALL>Countries at high risk for importation and subsequent spread</SMALL></SMALL><br> ‡ <SMALL><SMALL>Countries at high risk for importation and subsequent spread</SMALL></SMALL>
|-
|-
|}
|}

Revision as of 16:13, 24 October 2016

Vaccine Type Serotypes covered Number of Doses Vaccination Schedule in Endemic and High Risk Countries†
Birth 6 weeks 10 weeks 14 weeks
OPV *Monovalent (Serotype 2)
*Bivalent (Serotypes 1 & 3)‡
*Trivalent (Serotypes 1, 2, & 3)
3 to 4 doses
IPV *Serotype 1
*Serotype 2
*Serotype 3
4 doses
Countries at high risk for importation and subsequent spread
Countries at high risk for importation and subsequent spread